Cargando…

Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators

Background. Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias. The FibroScan (Echosens, France), a widely available, noninvasive device, is able to detect liver fibrosis and steatosis within this patient population. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Yin, Pranke, Stephanie, Rashidi, Farid, Nosib, Shravan, Worobetz, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350419/ https://www.ncbi.nlm.nih.gov/pubmed/28349045 http://dx.doi.org/10.1155/2017/7298032

Ejemplares similares

Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators
por: Pieri, Christopher, et al.
Publicado: (2021)

Diagnostic Accuracy of FibroScan and Factors Affecting Measurements
por: Oeda, Satoshi, et al.
Publicado: (2020)

Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators
por: Han, Donghoon, et al.
Publicado: (2019)

The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan–aspartate aminotransferase to predict severity of liver disease in children
por: Chaidez, Alexander, et al.
Publicado: (2022)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

Radiography of Cardiac Conduction Devices: A Pictorial Review of Pacemakers and Implantable Cardioverter Defibrillators
por: Torres-Ayala, Stephanie C, et al.
Publicado: (2014)

Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers
por: Watanabe, Eiichi, et al.
Publicado: (2017)

Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020)

Automated Implantable Cardioverter Defibrillator/Pacemaker Lead Fracture
por: Rubero, Jose, et al.
Publicado: (2020)

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology
por: Sahu, Palash, et al.
Publicado: (2023)

Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
por: Serra, Joao Tiago, et al.
Publicado: (2020)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

Implanted pacemaker and cardioverter-defibrillator in a patient with ectopia cordis
por: Pham, Tam Dan N., et al.
Publicado: (2019)

The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease
por: Wilder, Julius, et al.
Publicado: (2014)

Points to Be Considered When Applying FibroScan S Probe in Children With Biliary Atresia
por: Kim, Seung, et al.
Publicado: (2014)

A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
por: Jun, Baek Gyu, et al.
Publicado: (2017)

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
por: Berger, Arthur, et al.
Publicado: (2019)

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

Capsule endoscopy in patients with cardiac pacemakers, implantable cardioverter defibrillators and left heart assist devices
por: Bandorski, Dirk, et al.
Publicado: (2014)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
por: Abhilash, SP, et al.
Publicado: (2013)

The oral cavity is not a primary source for implantable pacemaker or cardioverter defibrillator infections
por: Eberhard, Jörg, et al.
Publicado: (2013)

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Correlates of hepatic stiffness by FibroScan(©) in a multicentric Italian cohort of HIV-infected patients
por: Tarquini, P, et al.
Publicado: (2010)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Establishing radiation therapy treatment planning effects involving implantable pacemakers and implantable cardioverter‐defibrillators
por: Gossman, Michael S., et al.
Publicado: (2009)

Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
por: Sanyal, Arun J., et al.
Publicado: (2023)

DF-4 defibrillator downgrade to pacemaker, a novel method of device downgrade for implantable cardioverter-defibrillator patients
por: Monkhouse, Christopher, et al.
Publicado: (2023)

The safety of electrical stimulation in patients with pacemakers and implantable cardioverter defibrillators: A systematic review
por: Badger, James, et al.
Publicado: (2017)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022)

Impact of new X-ray technology on patient dose in pacemaker and implantable cardioverter defibrillator (ICD) implantations
por: van Dijk, Joris D., et al.
Publicado: (2016)

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
por: Durango, Esteban, et al.
Publicado: (2013)

Liver Biopsy and FibroScan to Detect Early Histopathological Changes in Chronic HBV Patients Not Candidate for Treatment
por: Maklad, Sahar, et al.
Publicado: (2014)

Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan)
por: Hussain, Azhar, et al.
Publicado: (2019)

The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vcidi2fbdjbfdsfmcp9henh7h5